• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMERICAN MEDICAL SYSTEMS INC. ELEVATE/AMS TRANSVAGINAL MESH IMPLANT; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMERICAN MEDICAL SYSTEMS INC. ELEVATE/AMS TRANSVAGINAL MESH IMPLANT; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN Back to Search Results
Device Problem Migration (4003)
Patient Problems Erosion (1750); Failure of Implant (1924); Pain (1994); Perforation (2001); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/01/2022
Event Type  Injury  
Event Description
Elevate/ams transvaginal mesh device (b)(6) 2010 elevate/ams transvaginal mesh implanted.In (b)(6) 2022 pelvic pain, vaginal piercing sensation (b)(6) 2022 pcp visit, referred to gynecologist (b)(6); (b)(6) 2022 biopsy confirmed mesh erosion (b)(6) 2022 (b)(6) diagnosis mesh erosion with possible migration -surgery scheduled for (b)(6) 2022; 2010 operative notes, (b)(6) 2022 biopsy report, (b)(6) 2022 (b)(6) evaluation all available as pdf.Surgery required to cease further perforation/erosion/migration.Surgery scheduled 8/11/2022.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELEVATE/AMS TRANSVAGINAL MESH IMPLANT
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN
Manufacturer (Section D)
AMERICAN MEDICAL SYSTEMS INC.
10700 bren road west
minnetonka MN 55343
MDR Report Key14633117
MDR Text Key293693890
Report NumberMW5110190
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/07/2022
Patient Sequence Number1
Treatment
EZETIMIBE 10 MG PM; AREDS 2; ASPIRIN 81 MG/PM; CARVEDILOL 12.5 MG AM/PM; ESCITALOPRAM 5 MG PM ; ESTRACE CREAM 4/WK/PM ; FUROSEMIDE 20 MG AM ; HUMALOG 100 MG ; INSULIN PUMP ; LOSARTAN 50 MG AM ; MULTIVITAMIN ; PANTOPRAZOLE 40 MG AM/PM ; PRUE'S RXS ; RX: #0637166-15674 LEVOTHYROXINE .025 MCG AM ; SIMVASTATIN 40 MG PM; SPIRONOLACTONE 25 MG AM
Patient Outcome(s) Required Intervention; Disability;
Patient Age77 YR
Patient SexFemale
Patient Weight91 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-